世界の大容量非経口医薬品(LVP)販売市場2021

QYResearchが発行した調査報告書(QYR21JN7757)
◆英語タイトル:Global Large Volume Parenteral (LVP) Sales Market Report 2021
◆商品コード:QYR21JN7757
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月21日
◆ページ数:148
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥552,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥828,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,104,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の大容量非経口医薬品(LVP)市場について種類別(ソフトバッグLVP、ペットボトルLVP、ガラス瓶LVP)、用途別(一般注入、治療的注入、高栄養価注入)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・大容量非経口医薬品(LVP)市場の概要
・世界の主要地域別大容量非経口医薬品(LVP)市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の大容量非経口医薬品(LVP)市場規模2016-2021:種類別(ソフトバッグLVP、ペットボトルLVP、ガラス瓶LVP)
・世界の大容量非経口医薬品(LVP)市場予測2012-2027:種類別(ソフトバッグLVP、ペットボトルLVP、ガラス瓶LVP)
・世界の大容量非経口医薬品(LVP)市場規模2016-2021:用途別(一般注入、治療的注入、高栄養価注入)
・世界の大容量非経口医薬品(LVP)市場予測2012-2027:用途別(一般注入、治療的注入、高栄養価注入)
・大容量非経口医薬品(LVP)のアメリカ市場規模と予測2016-2021
・大容量非経口医薬品(LVP)のヨーロッパ市場規模と予測2016-2021
・大容量非経口医薬品(LVP)の中国市場規模と予測2016-2021
・大容量非経口医薬品(LVP)の日本市場規模と予測2016-2021
・大容量非経口医薬品(LVP)の東南アジア市場規模と予測2016-2021
・大容量非経口医薬品(LVP)のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Baxter Healthcare、Kelun Pharma、B. Braun、Fresenius、Teva Pharmaceutical Industries、Pfizer (Hospira)、Ostuka Pharmaceutical、CR Double-Crane、Pisa、Huaren、Patheon、Aspen Holdings、Beximco Pharma、Cook Pharmica、Albert David、PSI Ltd、Ozon Pharmaceuticals、BAG Healthcare、BML Parenteral Drugs)
・大容量非経口医薬品(LVP)の製造コスト分析
・販売チャネル、流通業者、顧客
・大容量非経口医薬品(LVP)の市場動向・機会・課題
・調査の結論
【レポートの概要】

Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.

Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.

Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
The first main kind is Soft Bag LVP, it hold a comparatively larger share in global market, which accounts for about 61.37% in 2018.
Another main kind is Glass Bottle LVP, for many companies, Glass Bottle LVP is attractive because of the market consumption need in the future. The Glass Bottle LVP share the rest 22.34% market share in 2018.
Plastic Bottle LVP hold the rest share, which accounts for about 16.29% in 2018.From the view of region, Asia-Pacific have a larger market share in 2018 which account for 46.29%, and will witness a stable growth in following years. North America and Europe hold a market share of 25.63% and 23.99% will still play an important role which cannot be ignored. Any changes from North America and Europe might affect the development trend of Large Volume Parenteral (LVP). South America and Middle East & Africa also play important roles in global market, but it will witness the comparatively low market share within selected regions.

Market Analysis and Insights: Global Large Volume Parenteral (LVP) Market
The global Large Volume Parenteral (LVP) market was valued at US$ 12750 in 2020 and will reach US$ 21150 million by the end of 2027, growing at a CAGR of 8.8% during 2022-2027.

Global Large Volume Parenteral (LVP) Scope and Market Size
The global Large Volume Parenteral (LVP) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Large Volume Parenteral (LVP) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Soft Bag LVP
Plastic Bottle LVP
Glass Bottle LVP
In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion

The Large Volume Parenteral (LVP) market is analysed and market size information is provided by regions (countries). Segment by Application, the Large Volume Parenteral (LVP) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Baxter Healthcare
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
CR Double-Crane
Pisa
Huaren
Patheon
Aspen Holdings
Beximco Pharma
Cook Pharmica
Albert David
PSI Ltd
Ozon Pharmaceuticals
BAG Healthcare
BML Parenteral Drugs

【レポートの目次】

1 Large Volume Parenteral (LVP) Market Overview
1.1 Large Volume Parenteral (LVP) Product Scope
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales by Type (2016 & 2021 & 2027)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Global Large Volume Parenteral (LVP) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Large Volume Parenteral (LVP) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Large Volume Parenteral (LVP) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Large Volume Parenteral (LVP) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Large Volume Parenteral (LVP) Price Trends (2016-2027)

2 Large Volume Parenteral (LVP) Estimates and Forecasts by Region
2.1 Global Large Volume Parenteral (LVP) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Region (2016-2021)
2.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2016-2021)
2.3 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Large Volume Parenteral (LVP) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.2 Europe Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.3 China Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.4 Japan Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
2.4.6 India Large Volume Parenteral (LVP) Estimates and Projections (2016-2027)
3 Global Large Volume Parenteral (LVP) Competition Landscape by Players
3.1 Global Top Large Volume Parenteral (LVP) Players by Sales (2016-2021)
3.2 Global Top Large Volume Parenteral (LVP) Players by Revenue (2016-2021)
3.3 Global Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Large Volume Parenteral (LVP) as of 2020)
3.4 Global Large Volume Parenteral (LVP) Average Price by Company (2016-2021)
3.5 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Large Volume Parenteral (LVP) Market Size by Type
4.1 Global Large Volume Parenteral (LVP) Historic Market Review by Type (2016-2021)
4.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2016-2021)
4.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2016-2021)
4.1.3 Global Large Volume Parenteral (LVP) Price by Type (2016-2021)
4.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Type (2022-2027)
4.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Type (2022-2027)
4.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Type (2022-2027)
5 Global Large Volume Parenteral (LVP) Market Size by Application
5.1 Global Large Volume Parenteral (LVP) Historic Market Review by Application (2016-2021)
5.1.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2016-2021)
5.1.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2016-2021)
5.1.3 Global Large Volume Parenteral (LVP) Price by Application (2016-2021)
5.2 Global Large Volume Parenteral (LVP) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Application (2022-2027)
5.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Application (2022-2027)
5.2.3 Global Large Volume Parenteral (LVP) Price Forecast by Application (2022-2027)

6 North America Large Volume Parenteral (LVP) Market Facts & Figures
6.1 North America Large Volume Parenteral (LVP) Sales by Company
6.1.1 North America Large Volume Parenteral (LVP) Sales by Company (2016-2021)
6.1.2 North America Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
6.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type
6.2.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
6.2.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
6.3 North America Large Volume Parenteral (LVP) Sales Breakdown by Application
6.3.1 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
6.3.2 North America Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)

7 Europe Large Volume Parenteral (LVP) Market Facts & Figures
7.1 Europe Large Volume Parenteral (LVP) Sales by Company
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Company (2016-2021)
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
7.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type
7.2.1 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
7.3 Europe Large Volume Parenteral (LVP) Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Large Volume Parenteral (LVP) Market Facts & Figures
8.1 China Large Volume Parenteral (LVP) Sales by Company
8.1.1 China Large Volume Parenteral (LVP) Sales by Company (2016-2021)
8.1.2 China Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
8.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type
8.2.1 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
8.2.2 China Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
8.3 China Large Volume Parenteral (LVP) Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)

9 Japan Large Volume Parenteral (LVP) Market Facts & Figures
9.1 Japan Large Volume Parenteral (LVP) Sales by Company
9.1.1 Japan Large Volume Parenteral (LVP) Sales by Company (2016-2021)
9.1.2 Japan Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
9.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type
9.2.1 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
9.3 Japan Large Volume Parenteral (LVP) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Large Volume Parenteral (LVP) Market Facts & Figures
10.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company
10.1.1 Southeast Asia Large Volume Parenteral (LVP) Sales by Company (2016-2021)
10.1.2 Southeast Asia Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
10.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type
10.2.1 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Large Volume Parenteral (LVP) Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)

11 India Large Volume Parenteral (LVP) Market Facts & Figures
11.1 India Large Volume Parenteral (LVP) Sales by Company
11.1.1 India Large Volume Parenteral (LVP) Sales by Company (2016-2021)
11.1.2 India Large Volume Parenteral (LVP) Revenue by Company (2016-2021)
11.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type
11.2.1 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2016-2021)
11.2.2 India Large Volume Parenteral (LVP) Sales Breakdown by Type (2022-2027)
11.3 India Large Volume Parenteral (LVP) Sales Breakdown by Application
11.3.1 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2016-2021)
11.3.2 India Large Volume Parenteral (LVP) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Large Volume Parenteral (LVP) Business
12.1 Baxter Healthcare
12.1.1 Baxter Healthcare Corporation Information
12.1.2 Baxter Healthcare Business Overview
12.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Products Offered
12.1.5 Baxter Healthcare Recent Development
12.2 Kelun Pharma
12.2.1 Kelun Pharma Corporation Information
12.2.2 Kelun Pharma Business Overview
12.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Kelun Pharma Large Volume Parenteral (LVP) Products Offered
12.2.5 Kelun Pharma Recent Development
12.3 B. Braun
12.3.1 B. Braun Corporation Information
12.3.2 B. Braun Business Overview
12.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 B. Braun Large Volume Parenteral (LVP) Products Offered
12.3.5 B. Braun Recent Development
12.4 Fresenius
12.4.1 Fresenius Corporation Information
12.4.2 Fresenius Business Overview
12.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Fresenius Large Volume Parenteral (LVP) Products Offered
12.4.5 Fresenius Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Corporation Information
12.5.2 Teva Pharmaceutical Industries Business Overview
12.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Products Offered
12.5.5 Teva Pharmaceutical Industries Recent Development
12.6 Pfizer (Hospira)
12.6.1 Pfizer (Hospira) Corporation Information
12.6.2 Pfizer (Hospira) Business Overview
12.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Products Offered
12.6.5 Pfizer (Hospira) Recent Development
12.7 Ostuka Pharmaceutical
12.7.1 Ostuka Pharmaceutical Corporation Information
12.7.2 Ostuka Pharmaceutical Business Overview
12.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Products Offered
12.7.5 Ostuka Pharmaceutical Recent Development
12.8 CR Double-Crane
12.8.1 CR Double-Crane Corporation Information
12.8.2 CR Double-Crane Business Overview
12.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CR Double-Crane Large Volume Parenteral (LVP) Products Offered
12.8.5 CR Double-Crane Recent Development
12.9 Pisa
12.9.1 Pisa Corporation Information
12.9.2 Pisa Business Overview
12.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pisa Large Volume Parenteral (LVP) Products Offered
12.9.5 Pisa Recent Development
12.10 Huaren
12.10.1 Huaren Corporation Information
12.10.2 Huaren Business Overview
12.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Huaren Large Volume Parenteral (LVP) Products Offered
12.10.5 Huaren Recent Development
12.11 Patheon
12.11.1 Patheon Corporation Information
12.11.2 Patheon Business Overview
12.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Patheon Large Volume Parenteral (LVP) Products Offered
12.11.5 Patheon Recent Development
12.12 Aspen Holdings
12.12.1 Aspen Holdings Corporation Information
12.12.2 Aspen Holdings Business Overview
12.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Aspen Holdings Large Volume Parenteral (LVP) Products Offered
12.12.5 Aspen Holdings Recent Development
12.13 Beximco Pharma
12.13.1 Beximco Pharma Corporation Information
12.13.2 Beximco Pharma Business Overview
12.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Beximco Pharma Large Volume Parenteral (LVP) Products Offered
12.13.5 Beximco Pharma Recent Development
12.14 Cook Pharmica
12.14.1 Cook Pharmica Corporation Information
12.14.2 Cook Pharmica Business Overview
12.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cook Pharmica Large Volume Parenteral (LVP) Products Offered
12.14.5 Cook Pharmica Recent Development
12.15 Albert David
12.15.1 Albert David Corporation Information
12.15.2 Albert David Business Overview
12.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Albert David Large Volume Parenteral (LVP) Products Offered
12.15.5 Albert David Recent Development
12.16 PSI Ltd
12.16.1 PSI Ltd Corporation Information
12.16.2 PSI Ltd Business Overview
12.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 PSI Ltd Large Volume Parenteral (LVP) Products Offered
12.16.5 PSI Ltd Recent Development
12.17 Ozon Pharmaceuticals
12.17.1 Ozon Pharmaceuticals Corporation Information
12.17.2 Ozon Pharmaceuticals Business Overview
12.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Products Offered
12.17.5 Ozon Pharmaceuticals Recent Development
12.18 BAG Healthcare
12.18.1 BAG Healthcare Corporation Information
12.18.2 BAG Healthcare Business Overview
12.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 BAG Healthcare Large Volume Parenteral (LVP) Products Offered
12.18.5 BAG Healthcare Recent Development
12.19 BML Parenteral Drugs
12.19.1 BML Parenteral Drugs Corporation Information
12.19.2 BML Parenteral Drugs Business Overview
12.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 BML Parenteral Drugs Large Volume Parenteral (LVP) Products Offered
12.19.5 BML Parenteral Drugs Recent Development

13 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
13.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
13.4 Large Volume Parenteral (LVP) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Large Volume Parenteral (LVP) Distributors List
14.3 Large Volume Parenteral (LVP) Customers

15 Market Dynamics
15.1 Large Volume Parenteral (LVP) Market Trends
15.2 Large Volume Parenteral (LVP) Drivers
15.3 Large Volume Parenteral (LVP) Market Challenges
15.4 Large Volume Parenteral (LVP) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の大容量非経口医薬品(LVP)販売市場2021(Global Large Volume Parenteral (LVP) Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。